Neogen Chemicals Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a consolidated revenue of ₹861.96 crore for the full financial year and recommended a final dividend of Re. 1 per equity share. Additionally, the company disclosed revised timelines and cost estimates for its ongoing Dahej and Pakhajan projects, now totaling ₹1,795 crore in projected costs, alongside updates to its insider trading code.
Financial Performance Overview
For the financial year ended March 31, 2026, Neogen Chemicals reported a standalone total income of ₹871.31 crore, with a profit after tax of ₹46.96 crore. On a consolidated basis, the company achieved a total income of ₹868.10 crore and a profit after tax of ₹28.75 crore for the same period. The Board of Directors has recommended a final dividend of Re. 1 per equity share for the fiscal year 2025-26, subject to shareholder approval at the upcoming 37th Annual General Meeting.
Strategic Project Developments
The company provided significant updates regarding its wholly-owned subsidiary, Neogen Ionics Limited. The project costs and timelines for the Dahej Phase 1 and Pakhajan Phase 2 projects have been revised. The Dahej Phase 1 project is now expected to be completed by February 2027 with a cost of ₹428 crore, while the Pakhajan Phase 2 project is slated for March 2027 with an investment of ₹1,367 crore. The total project cost is now estimated at ₹1,795 crore, with additional capital expenditure attributed to design optimization, Japanese technology integration, and increased localization.
Governance and Corporate Updates
In addition to financial disclosures, Neogen Chemicals has amended its Code for Prevention of Insider Trading to ensure stronger governance standards. Furthermore, the company successfully completed a preferential allotment of 10,00,000 equity shares to a promoter group member, Cadamba Solutions Private Limited, in April 2026, raising ₹161 crore in capital. The company also confirmed an unmodified audit opinion from its statutory auditors regarding the financial results.
Source: BSE
